Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024

Clinical Data to be Presented at Medical Conference in Early 2025

Read more at globenewswire.com

MICROBOT MEDICAL INC

NASDAQ:MBOT (2/11/2025, 3:03:04 PM)

2.07

-0.24 (-10.39%)

MBOT Stock Chart

MBOT Technical Analysis

MBOT Fundamental Analysis

MBOT Analyst Ratings

MBOT Earnings Estimates

Interactive MBOT Stock Chart

Nasdaq Stock Screener

USA Stock Screener

MBOT Latest News and Analysis

Follow ChartMill for more

Follow us on YouTube